Zions Bancorporation’s Immunogen Inc IMGN Stock Holding History

Zions Bancorporation’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-57	Closed	–	–	1078
2021 Q3	$0	Sell	57 -105	-65%	-$607	﹤0.01%	1074
2021 Q2	$1K	Buy	+162	New	+$1.13K	﹤0.01%	971

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zions Bancorporation's IMGN Position: Q4 2021 in Review

Zions Bancorporation sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 57 shares.

Zions Bancorporation first reported a position in IMGN in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

Zions Bancorporation reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
Zions Bancorporation sold 57 Immunogen Inc shares in Q4 2021.
Zions Bancorporation first reported a position in Immunogen Inc in Q2 2021 and held it in 2 quarters.
Zions Bancorporation's Immunogen Inc position peaked at $1K in Q2 2021.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Zions Bancorporation's 13F filing for Q4 2021, filed 11 Feb 2022.